Home / Funds / Voleon Capital Management LP
Voleon Capital Management LP
The short positions this fund discloses today, across every market.
8 open positions
4 Markets
July 21, 2026 Last disclosure
549300EJ1ZB4YYIOMD56 LEI
| Issuer | Market | % of capital | Since |
|---|---|---|---|
| Zealand Pharma A/S | Denmark | 1.11% | May 19, 2026 |
| B&M European Value Retail S.A. | Germany | 0.79% | April 20, 2026 |
| Oryzon Genomics, S.A. | Spain | 0.63% | July 3, 2026 |
| Gubra A/S | Denmark | 0.59% | March 23, 2026 |
| Lang & Schwarz Aktiengesellschaft | Germany | 0.59% | February 2, 2022 |
| Tubacex, S.A. | Spain | 0.59% | June 30, 2026 |
| Medigene AG | Germany | 0.55% | December 4, 2017 |
| Atos Group | France | 0.50% | July 21, 2026 |
History of disclosures
| Date | Issuer | Market | % of capital | End of publication |
|---|---|---|---|---|
| March 2, 2026 | Fugro N.V. | Netherlands | 0.66% | still open |
| March 2, 2026 | Bonesupport Holding AB | Sweden | 0.61% | still open |
| March 2, 2026 | Gubra A/S | Denmark | 0.60% | March 2, 2026 |
| March 2, 2026 | Capital B | France | 0.52% | March 5, 2026 |
| March 2, 2026 | DBV Technologies | France | 0.50% | August 4, 2026 |
| March 2, 2026 | Edenred | France | 0.50% | July 7, 2026 |
| February 27, 2026 | Hansa Biopharma AB | Sweden | 1.00% | still open |
| February 27, 2026 | Fugro N.V. | Netherlands | 0.70% | still open |
| February 27, 2026 | Teleperformance | France | 0.59% | April 14, 2026 |
| February 27, 2026 | Median Technologies | France | 0.51% | April 21, 2026 |
| February 26, 2026 | Avantium N.V. | Netherlands | 1.78% | still open |
| February 26, 2026 | 2CRSI | France | 1.52% | June 26, 2026 |
| February 26, 2026 | Capital B | France | 0.68% | March 5, 2026 |
| February 25, 2026 | Capital B | France | 0.73% | March 5, 2026 |
| February 25, 2026 | DBV Technologies | France | 0.49% | February 27, 2026 |
| February 25, 2026 | Edenred | France | 0.49% | February 27, 2026 |
| February 24, 2026 | Avantium N.V. | Netherlands | 1.85% | still open |
| February 24, 2026 | 2CRSI | France | 1.42% | June 26, 2026 |
| February 24, 2026 | Link Mobility Group Holding | Norway | 1.00% | February 25, 2026 |
| February 23, 2026 | 2CRSI | France | 1.36% | June 26, 2026 |
| February 23, 2026 | Capital B | France | 0.88% | March 5, 2026 |
| February 23, 2026 | DBV Technologies | France | 0.50% | February 27, 2026 |
| February 23, 2026 | Digital Value Spa | Italy | 0.47% | still open |
| February 20, 2026 | Capital B | France | 0.95% | March 5, 2026 |
| February 20, 2026 | MilDef Group AB | Sweden | 0.90% | still open |
| February 20, 2026 | Sinch AB (publ) | Sweden | 0.74% | still open |
| February 20, 2026 | Digital Value Spa | Italy | 0.54% | still open |
| February 20, 2026 | Bonesupport Holding AB | Sweden | 0.51% | still open |
| February 19, 2026 | Avantium N.V. | Netherlands | 1.97% | still open |
| February 19, 2026 | Alfen N.V. | Netherlands | 1.84% | still open |
| February 19, 2026 | 2CRSI | France | 1.20% | June 26, 2026 |
| February 19, 2026 | Avio SPA | Italy | 1.15% | still open |
| February 19, 2026 | MilDef Group AB | Sweden | 0.86% | still open |
| February 19, 2026 | Teleperformance | France | 0.60% | April 14, 2026 |
| February 18, 2026 | Alfen N.V. | Netherlands | 1.77% | still open |
| February 18, 2026 | Capital B | France | 1.08% | March 5, 2026 |
| February 18, 2026 | Hansa Biopharma AB | Sweden | 0.90% | still open |
| February 18, 2026 | Digital Value Spa | Italy | 0.61% | still open |
| February 18, 2026 | Edenred | France | 0.50% | February 27, 2026 |
| February 17, 2026 | Alfen N.V. | Netherlands | 1.68% | still open |
| February 17, 2026 | Storytel AB (publ) | Sweden | 0.71% | still open |
| February 17, 2026 | Sinch AB (publ) | Sweden | 0.62% | still open |
| February 17, 2026 | Fugro N.V. | Netherlands | 0.60% | still open |
| February 17, 2026 | Nordic Semiconductor | Norway | 0.52% | March 5, 2026 |
| February 16, 2026 | Avantium N.V. | Netherlands | 2.09% | still open |
| February 16, 2026 | 2CRSI | France | 1.10% | June 26, 2026 |
| February 16, 2026 | Hansa Biopharma AB | Sweden | 0.84% | still open |
| February 16, 2026 | Sinch AB (publ) | Sweden | 0.50% | still open |
| February 13, 2026 | Alfen N.V. | Netherlands | 1.51% | still open |
| February 13, 2026 | Gubra A/S | Denmark | 0.59% | February 13, 2026 |
The funds short on the same companies
- Citadel Advisors LLC 2 companies in common
- AHL Partners LLP 1 company in common
- ActusRayPartners Limited 1 company in common
- Capital Fund Management 1 company in common
- Citadel Advisors II LLC 1 company in common
- Connor Clark & Lunn Investment Management Ltd 1 company in common
- D. E. Shaw & Co., L.P. 1 company in common
- GSA Capital Partners LLP 1 company in common
- Jennison Associates LLC 1 company in common
- Jupiter Asset Management Limited 1 company in common
- Marshall Wace LLP 1 company in common
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Voleon Capital Management LP, data as at July 21, 2026, https://www.quivad.com/detenteur/voleon-capital-management-lp?page=9